Scientists aim to forecast migraine pain using wearable sensors and early symptoms
NCT ID NCT06459635
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study explores whether migraine attacks can be predicted before the headache phase begins. Researchers will monitor people with episodic migraine (10–14 migraine days per month) using a wearable device that tracks heart rate and other body signals, along with a diary of early warning symptoms. The goal is to develop a personalized algorithm that could one day give patients a heads-up before pain strikes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a wearable device or app that warns people with migraine when an attack is about to begin, allowing earlier treatment.
What could go wrong
This is an early-stage observational study with only 70 participants. The prediction method may not work for everyone or may be too complex for daily use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Atogepant vs Topiramate for Migraine Prevention NCT05748483
- CHRONOpS Study: Migraine Premonitory Symptoms (NCT07681466)
- Rimegepant for Migraine: Real-World Study NCT06467370
- Cocoa Flavanols for Migraine Pilot Study (NCT06808230)
- AJOVY Long-Term Safety Study for Migraine (NCT05342493)
- Fremanezumab for Migraine Prevention in Kids (NCT04458857)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Hospital Universitario de La Princesa
RECRUITINGMadrid, Madrid, 28006, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••